<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04662268</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0639</org_study_id>
    <nct_id>NCT04662268</nct_id>
  </id_info>
  <brief_title>Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis</brief_title>
  <official_title>Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our objective is to determine a prognostic score including CT, clinical and biological&#xD;
      criteria predicting the serious (death / surgery) or non-serious (medical treatment)&#xD;
      evolution of ischemic colitis and therefore possibly modify the therapeutic management&#xD;
      (propose surgical treatment for a severe form based on prognostic score).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">November 30, 2020</completion_date>
  <primary_completion_date type="Actual">November 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complication rate of ischemic colitis</measure>
    <time_frame>1 day</time_frame>
    <description>Severe (surgery and/or death) or non severe form of ischemic colitis (medical treatment) : analysis of radiological, biological and clinical data is performed at the time of acute episode of ischemic colitis when the patient is admitted to the hospital or during the stay of the patient previously present in the hospital for another condition</description>
  </primary_outcome>
  <enrollment type="Actual">206</enrollment>
  <condition>Ischemic Colitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Single-center retrospective cohort (center: CHU de Montpellier) of patients admitted&#xD;
        between january 2014 and december 2019 at the CHU, over 18 years of age and having&#xD;
        presented ischemic colitis during their stay, with completion of an injected&#xD;
        abdomino-pelvic scanner within 6 hours of onset of symptoms, then proven by surgery or&#xD;
        endoscopy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Age &gt; or = at 18 years old;&#xD;
&#xD;
          -  Performing an abdomino-pelvic scan injected within 6 hours of the onset of symptoms;&#xD;
&#xD;
          -  Ischemic colitis proven by endoscopy or surgical data.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  CT scan performed without injection and / or after 6 hours following the onset of&#xD;
             symptoms;&#xD;
&#xD;
          -  Unproven ischemic colitis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrice TAOUREL, MD-PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>December 3, 2020</last_update_submitted>
  <last_update_submitted_qc>December 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemic colitis</keyword>
  <keyword>computed tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ischemic</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

